Dr. Lal PathLabs Limited (LALPATHLAB.NS)
INR 3018.6
(-0.67%)
INR 3018.6
(-0.67%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.83 Billion INR | -474.45% |
| 2022 | 1.55 Billion INR | 1.01% |
| 2021 | 1.54 Billion INR | 264.2% |
| 2020 | -939.32 Million INR | -39.47% |
| 2019 | -673.49 Million INR | 47.95% |
| 2018 | -1.29 Billion INR | -545.39% |
| 2017 | -200.48 Million INR | -33.2% |
| 2016 | -150.51 Million INR | 12.4% |
| 2015 | -171.81 Million INR | 26.21% |
| 2014 | -232.84 Million INR | -56.3% |
| 2013 | -148.97 Million INR | 11.93% |
| 2012 | -169.15 Million INR | -112.42% |
| 2011 | -79.63 Million INR | -152.41% |
| 2010 | 151.95 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 9.42 Billion INR | 261.57% |
| 2024 Q2 | -651 Million INR | -90.27% |
| 2023 FY | -5.83 Billion INR | -474.45% |
| 2023 Q1 | 8.15 Billion INR | 423.3% |
| 2023 Q3 | 8.96 Billion INR | 400.45% |
| 2023 Q2 | 1.79 Billion INR | -78.02% |
| 2023 Q4 | -5.83 Billion INR | -165.05% |
| 2022 Q2 | 3.75 Billion INR | -44.88% |
| 2022 Q4 | 1.55 Billion INR | -76.02% |
| 2022 Q1 | 6.81 Billion INR | 341.94% |
| 2022 FY | 1.55 Billion INR | 1.01% |
| 2022 Q3 | 6.49 Billion INR | 72.96% |
| 2021 Q3 | 11.25 Billion INR | 1112.41% |
| 2021 Q1 | 9.84 Billion INR | 1147.59% |
| 2021 FY | 1.54 Billion INR | 264.2% |
| 2021 Q4 | 1.54 Billion INR | -86.3% |
| 2021 Q2 | -1.11 Billion INR | -111.3% |
| 2020 Q3 | 8.36 Billion INR | 758.94% |
| 2020 Q4 | -939.32 Million INR | -111.23% |
| 2020 Q2 | -1.26 Billion INR | -117.34% |
| 2020 Q1 | 7.31 Billion INR | 1186.5% |
| 2020 FY | -939.32 Million INR | -39.47% |
| 2019 Q1 | 6.73 Billion INR | 620.63% |
| 2019 Q3 | 7.96 Billion INR | 756.1% |
| 2019 FY | -673.49 Million INR | 47.95% |
| 2019 Q4 | -673.49 Million INR | -108.46% |
| 2019 Q2 | -1.21 Billion INR | -118.02% |
| 2018 Q2 | -1.47 Billion INR | -132.34% |
| 2018 FY | -1.29 Billion INR | -545.39% |
| 2018 Q4 | -1.29 Billion INR | -119.89% |
| 2018 Q3 | 6.5 Billion INR | 541.92% |
| 2018 Q1 | 4.55 Billion INR | 2370.55% |
| 2017 FY | -200.48 Million INR | -33.2% |
| 2017 Q1 | 3.42 Billion INR | 2378.1% |
| 2017 Q2 | -178 Million INR | -105.19% |
| 2017 Q3 | 4.41 Billion INR | 2579.78% |
| 2017 Q4 | -200.48 Million INR | -104.54% |
| 2016 FY | -150.51 Million INR | 12.4% |
| 2016 Q3 | 3.44 Billion INR | 244.02% |
| 2016 Q4 | -150.51 Million INR | -104.36% |
| 2016 Q2 | -2.39 Billion INR | -181.48% |
| 2016 Q1 | 2.93 Billion INR | 1804.38% |
| 2015 Q4 | -172.47 Million INR | 0.0% |
| 2015 Q2 | -137.99 Million INR | -107.41% |
| 2015 Q1 | 1.86 Billion INR | 899.27% |
| 2015 FY | -171.81 Million INR | 26.21% |
| 2014 FY | -232.84 Million INR | -56.3% |
| 2014 Q4 | -232.84 Million INR | 0.0% |
| 2013 FY | -148.97 Million INR | 11.93% |
| 2012 FY | -169.15 Million INR | -112.42% |
| 2011 FY | -79.63 Million INR | -152.41% |
| 2010 FY | 151.95 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 1.06 Billion INR | 649.119% |
| Metropolis Healthcare Limited | 1.25 Billion INR | 563.571% |
| Thyrocare Technologies Limited | 24.5 Million INR | 23912.245% |
| Vijaya Diagnostic Centre Limited | 1.86 Billion INR | 413.479% |
| Vimta Labs Limited | -66 Million INR | -8739.394% |